Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0396 USD | -1.00% | +32.00% | -26.80% |
May. 14 | Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 04 | Filament Health Corp. Announces Change to Board of Directors | CI |
Business Summary
Number of employees: 13
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Psychedelic Medicines
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +484.63% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +484.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 38 | 20-06-07 | |
Ryan Moss
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-07 |
Lisa Ranken
COO | Chief Operating Officer | - | 21-03-07 |
Jon Conlin
BRD | Director/Board Member | 38 | 21-02-25 |
Andry Tjahyana
PRN | Corporate Officer/Principal | - | 21-12-31 |
Jeff Fellows
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Wagner
BRD | Director/Board Member | 55 | 21-04-15 |
Chief Executive Officer | 38 | 20-06-07 | |
Director/Board Member | 53 | 22-08-22 | |
Jon Conlin
BRD | Director/Board Member | 38 | 21-02-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 211,209,527 | 119,315,727 ( 56.49 %) | 0 | 56.49 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-26.80% | 8.36M | |
+6.07% | 217B | |
+11.69% | 190B | |
+18.16% | 143B | |
+29.77% | 111B | |
+0.65% | 64.59B | |
+14.32% | 52.36B | |
+2.06% | 48.45B | |
-5.42% | 38.03B | |
-1.31% | 35.6B |
- Stock Market
- Equities
- FLHLF Stock
- Company Filament Health Corp.